6 completed, 2 recruiting, 1 not yet recruiting. 7 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 5, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow AKL-T01: new trials by email Literature Review of AKL-T01 trials Research Report on AKL-T01
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brain Function and Cognitive Control Training in Children With Obsessive-Compulsive Symptoms Cognitive Control Training - Obsessive-Compulsive Symptoms, Cognitive Control | Not applicable | Not yet recruiting | Columbia University | 60 | 2026-10-15 | 2026-09-24 |
| Cognitive Control Targets for the Treatment of Obsessive Compulsive Disorder in Young Children Cognitive Control Training (CT) - Obsessive-Compulsive Disorder in Children | Not applicable | Recruiting | Columbia University | 60 | 2024-06-27 | 2025-11-06 |
| A Digital Intervention for Post-Stroke Depression and Executive Dysfunction AKL-T01, Metacognitive Strategy Training - Executive Dysfunction, Depression | Phase 2 | Recruiting | Weill Medical College of Cornell University | 70 | 2023-03-01 | 2026-08-20 |
| Cognitive Training in Survivors of Covid-19: A Randomized Trial AKL-T01, Control Group - Covid19, Cognitive Impairment | Not applicable | Completed | Vanderbilt University Medical Center | 83 | 2021-08-03 | 2026-10-02 |
| Improving Cognitive Health in COVID-19 Survivors AKL-T01 - Cognitive Dysfunction, Covid19 | Phase 2 | Completed | Weill Medical College of Cornell University | 110 | 2021-07-13 | 2024-02-29 |
| Software Treatment for Actively Reducing Severity of ADHD in Adolescents (STARS-ADHD-Adolescents) AKL-T01 - Attention Deficit Hyperactivity Disorder | Not applicable | Completed | Akili Interactive Labs, Inc. | 165 | 2021-06-29 | 2023-08-14 |
| Electroencephalogram (EEG) Study of Inattention Following Treatment With AKL-T01 AKL-T01 - Attention Deficit Hyperactivity Disorder | Not applicable | Completed | Akili Interactive Labs, Inc. | 28 | 2019-05-10 | 2023-11-14 |
| Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant AKL-T01 - Attention Deficit Hyperactivity Disorder | Not applicable | Completed | Akili Interactive Labs, Inc. | 206 | 2018-12-28 | 2023-08-09 |
| Software Treatment for Actively Reducing Severity of ADHD AKL-T01, AKL-T09 - Attention Deficit Disorder With Hyperactivity | Not applicable | Completed | Akili Interactive Labs, Inc. | 348 | 2016-05-01 | 2020-08-14 |
Attention Deficit Disorder with Hyperactivity (4) · COVID-19 (2) · Cognitive Dysfunction (2) · Depression (1) · Stroke (1)
Akili Interactive Labs, Inc. (4) · Columbia University (2) · Weill Medical College of Cornell University (2) · Vanderbilt University Medical Center (1)
United States (9)
Abhishek Jaywant, PhD (1) · Dana Diaz, PhD (1) · Daniel Lazkowitz, MD, PhD (1) · Elysa J Marco, MD (1) · Faith Gunning, PhD (1) · Rachel Marsh (1) · Scott Kollins, PhD (1)
PMID 38685016, PMID 39128918, PMID 33334505, PMID 34972140
K01MH141273 (1), K23MH129849 (1), R61MH129544 (1)